Loading...
Brookdale Senior Living Inc (BKD) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive analyst ratings and a bullish outlook on EBITDA growth, the company's recent financial performance is weak, with significant declines in revenue, net income, and EPS. Additionally, hedge funds are selling heavily, and there are no strong technical or proprietary trading signals to support an immediate buy decision. Holding off for now and monitoring the company's performance and market trends would be prudent.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 41.197, showing no clear signal. Moving averages are converging, suggesting indecision in price direction. Key support and resistance levels are S1: 14.794 and R1: 16.75, with the stock trading near the pivot at 15.17.

Analysts have raised price targets and maintain Buy or Overweight ratings, citing strong EBITDA growth potential, improved occupancy rates, and strategic pricing initiatives. The company's Q4 2025 report showed a strong adjusted EBITDA of $458 million and an optimistic revenue growth outlook for 2026.
Hedge funds are selling heavily, with an 885.30% increase in selling activity last quarter. AYAL Capital Advisors fully exited its position, signaling potential lack of confidence. Financial performance in Q4 2025 was weak, with significant YoY declines in revenue (-95.30%), net income (-52.38%), and EPS (-54.05%). Gross margin also dropped drastically to -1553.99%.
In Q4 2025, the company reported a significant decline in revenue (-95.30% YoY), net income (-52.38% YoY), and EPS (-54.05% YoY). Gross margin fell sharply to -1553.99%, reflecting operational inefficiencies and challenges.
Analysts are bullish, with multiple upgrades and raised price targets. BofA raised the price target to $19.50, citing strong underlying trends and mid-teens EBITDA growth potential. Barclays and RBC also raised price targets, emphasizing improved occupancy rates and pricing strategies.